Lupin gets USFDA approval for Pitavastatin tablets

By Indo Asian News Service | Friday, December 30, 2016 | 8:48:03 PM IST (+05:30 GMT) Comment 0 Comment

New Delhi, Dec 30 (IANS) Pharmaceutical major Lupin on Friday said it has received tentative approval for its cholesterol lowering Pitavastatin tablets from the US Food and Drug Administration (USFDA).

New Delhi, Dec 30 (IANS) Pharmaceutical major Lupin on Friday said it has received tentative approval for its cholesterol lowering Pitavastatin tablets from the US Food and Drug Administration (USFDA).

"Pharma Major Lupin announced today that it has received tentative approval for its Pitavastatin tablets, 1 mg, 2 mg and 4 mg from the United States Food and Drug Administration (FDA) to market a generic version of Kowa Company Limited's (Kowa) Livalo Tablets 1 mg, 2 mg and 4 mg," the pharmaceutical company said in a regulatory filing to the BSE.

"Pitavastatin tablets are indicated as an adjunctive therapy to diet to reduce elevated total cholesterol, low-density lipoprotein cholesterol, apolipoprotein B, triglycerides and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia," it added.

--IANS

ppg/vd

Do you like this article?

Copyright  Indo-Asian News Service

User Rating  Rating(0 Votes)

Views  114

Readers Feedback & Discussion

Join India Forums for free to comment on this story. Have an account already? Login to comment.

News Health Articles Index

  

Articles in National, Health

Art - Culture Business Diaspora
Education Health Politics
Religion Sports Sci-Tech
Travel

AROUND THE WORLD NOW

Asia America Australia
Africa Europe Gulf-Middle East
Pakistan Nepal Bhutan
Sri Lanka Bangladesh Maldives

Disclaimer: All Logos and Pictures of various Channels, Shows, Artistes, Media Houses, Companies, Brands etc. belong to their respective owners, and are used to merely visually identify the Channels, Shows, Companies, Brands, etc. to the viewer. Incase of any issue please contact the webmaster.